C4 Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in C4 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including C4 Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in C4 Therapeutics by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $57k | 6.9k | 8.17 |
| 2023-09-30 | $23k | 12k | 1.86 |
| 2023-06-30 | $26k | 9.4k | 2.75 |
| 2023-03-31 | $12k | 3.8k | 3.13 |
| 2022-12-31 | $9.0k | 1.5k | 6.01 |
| 2022-09-30 | $89k | 10k | 8.77 |
| 2022-06-30 | $21k | 2.8k | 7.45 |
| 2022-03-31 | $268k | 11k | 24.30 |
| 2021-12-31 | $151k | 4.8k | 31.25 |
| 2021-09-30 | $126k | 2.8k | 44.74 |
| 2021-06-30 | $45k | 1.1k | 39.04 |
| 2021-03-31 | $76k | 2.1k | 36.67 |
| 2020-12-31 | $8.5k | 286 | 29.70 |
More positions owned by Tower Research Capital
Home Depot (HD)
View all positions for Tower Research Capital